Research Integrity and Compliance


The mission of the Office of Research Integrity and Compliance (ORIC) is to assist the Emory Community and the Office of Research Administration (ORA) staff in promoting research compliance with Emory policies and Federal Regulations. ORIC is available for research compliance inquiries and provides training and support as needed. We facilitate the review of research involving human stem cells. We collaborate with ORA offices and researchers in modifying and creating new polices and guidance. We track changes to current regulations to support Emory's research compliance. We oversee the review of our internal ORA research compliance processes, including FDA and Controlled Substance and Dangerous Drug matters, and investigate and support the Research Integrity Officer (RIO) during the review of research misconduct allegations and research noncompliance investigations.

Highlights

Contact us!

If you've come across any research compliance issues, feel free to contact us and let us know. We're here to assist!

Submit your concern
Contact the team

Georgia Board of Pharmacy and DEA license registration

Register your new or existing licenses with ORIC; update your license after your renewal.

GBP License
DEA License

IND/IDE Submission Help

Contact us for consultations about your IND or IDE submissions to prevent delays.

Devices
Drugs or Biologics

ORIC OFFICE HOURS- TUESDAYS AT 9:30 AM

Join us every Tuesday at 9:30 am to discuss any pressing questions with your team. We can answer any CS/DD, research noncompliance/misconduct, ESCRO, Responsible Conduct for Research and any other topic you may have. If we don't know the answer, we will put you in contact with the correct group! No registration is needed, and these sessions are not recorded.

Zoom Meeting Link

News

Covetrus on Exclusionary supplier list and McKesson requiring DEA CSOS Certificate

Health and Human Services (HHS) has placed Covetrus on an exclusionary supplier list and as a result Emory Procurement has removed Covetrus as a supplier from Emory Express. Emory Researchers will need to obtain their pharmaceuticals and lab supplies from other vendors. Please see the below flyer for a list of alternative suppliers and the contact information for setting up an account. Starting March 31, 2025, McKesson will no longer accept paper DEA form 222s for Schedule II orders; instead a DEA CSOS certificate and pin number will be needed to place orders. Registrants affected by this change should contact ORIC or Emory’s McKesson point of contact, Michael Cecelia at Michael.Cecelia@McKesson.com, with assistance in setting up a CSOS account. It can take up to three months to obtain a CSOS certificate from DEA.

Vendor Flyer

ORI Updated interactive videos "The Lab" and "The Research Clinic"

The Office of Research Integrity (ORI) have updated their interactive videos showing different scenarios in where a research misconduct issue may occur. ORI said that "The Lab and The Research Clinic better reflect current standards of appropriate workplace behavior in research settings." Find the videos below.

The Lab
The Research Clinic

REGISTER TO THE CS/DD WEBINAR SERIES

Each webinar of the "Managing Controlled Substances & Dangerous Drugs in Research" series last 30 minutes, with a short presentation and questions from the audience. Find the recordings on our Training page.

Zoom meeting link
Recordings

Research Misconduct Prevention Infographic

Review the process the RIO team follows when reviewing cases of research misconduct, as well as resources and other information.

Preventing RM Infographic

Training to Prevent Research Misconduct

ORIC works closely with our RIO to educate the research community in the prevention of research misconduct. We are available to present at your lab, school or department.

Schedule a Training

Authorship Infographic

Review this infographic to learn who to include in a publication and the responsibilities of being an author.

Access the infographic here